Glenn Dubin

Insider Reports History

Entity
Individual
Location
C/O Highbridge Capital Management, Llc, 40 West 57 Th Street, 32 Nd Floor, New York, New York
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Glenn Dubin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
C4 Therapeutics, Inc. Director Common Stock 771K $6.24M $8.10 Apr 1, 2024 By DF Investment Partners LLC
C4 Therapeutics, Inc. Director Common Stock 22.1K $179K $8.10 Apr 1, 2024 Direct
C4 Therapeutics, Inc. Director Common Stock 20K $162K $8.10 Apr 1, 2024 By G&E Dubin Family Foundation

Insider Reports Filed by Glenn Dubin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CCCC C4 Therapeutics, Inc. Apr 1, 2024 1 $11K 4 Apr 2, 2024 Director
CCCC C4 Therapeutics, Inc. Jan 2, 2024 1 $11K 4 Jan 3, 2024 Director
CCCC C4 Therapeutics, Inc. Oct 2, 2023 1 $11K 4 Oct 3, 2023 Director
CCCC C4 Therapeutics, Inc. Jul 3, 2023 1 $11K 4 Jul 5, 2023 Director
CCCC C4 Therapeutics, Inc. Jun 15, 2023 1 $0 4 Jun 16, 2023 Director
CCCC C4 Therapeutics, Inc. Apr 3, 2023 1 $11K 4 Apr 4, 2023 Director
CCCC C4 Therapeutics, Inc. Jan 3, 2023 1 $11K 4 Jan 4, 2023 Director
CCCC C4 Therapeutics, Inc. Oct 3, 2022 1 $11K 4 Oct 4, 2022 Director
CCCC C4 Therapeutics, Inc. Jul 1, 2022 1 $11K 4 Jul 5, 2022 Director
CCCC C4 Therapeutics, Inc. Jun 22, 2022 1 $0 4 Jun 23, 2022 Director
CCCC C4 Therapeutics, Inc. Apr 4, 2022 1 $10K 4 Apr 5, 2022 Director
CCCC C4 Therapeutics, Inc. Jan 4, 2022 1 $6.28K 4 Jan 18, 2022 Director
CCCC C4 Therapeutics, Inc. Oct 4, 2021 1 $6.21K 4 Oct 5, 2021 Director
CCCC C4 Therapeutics, Inc. Jul 2, 2021 1 $6.24K 4 Aug 20, 2021 Director